Three UB research groups prove cholesterol plays a key role in cell migration

From left to right, researchers Carles Enrich, Meritxell Reverter, Anna Álvarez Guaita, Ana García Melero, Carles Rentero and Elsa Meneses, at the Faculty of Medicine of UB.
From left to right, researchers Carles Enrich, Meritxell Reverter, Anna Álvarez Guaita, Ana García Melero, Carles Rentero and Elsa Meneses, at the Faculty of Medicine of UB.
Research
(21/05/2014)

UB researchers led by Professor Carles Enrich, from the Department of Cell Biology, Immunology and Neurosciences of the Faculty of Medicine at the University of Barcelona (UB) and CELLEX Biomedical Research Centre of IDIBAPS, have found that cholesterol plays a key role in cell mobility and tissue invasion. The results of the study prove that the accumulation of LDL cholesterol cells —the one carried by low-density lipoproteins— may play a crucial role in promoting cell mobility. On the contrary, high levels of HDL cholesterol —the one carried by high-density lipoproteins— may avoid cell propagation. This is a key study to better understand cancer metastasis, the process in which cancer cells invade healthy tissues, and foster the discussion on the relationship between cholesterol levels and cancer incidence.

From left to right, researchers Carles Enrich, Meritxell Reverter, Anna Álvarez Guaita, Ana García Melero, Carles Rentero and Elsa Meneses, at the Faculty of Medicine of UB.
From left to right, researchers Carles Enrich, Meritxell Reverter, Anna Álvarez Guaita, Ana García Melero, Carles Rentero and Elsa Meneses, at the Faculty of Medicine of UB.
Research
21/05/2014

UB researchers led by Professor Carles Enrich, from the Department of Cell Biology, Immunology and Neurosciences of the Faculty of Medicine at the University of Barcelona (UB) and CELLEX Biomedical Research Centre of IDIBAPS, have found that cholesterol plays a key role in cell mobility and tissue invasion. The results of the study prove that the accumulation of LDL cholesterol cells —the one carried by low-density lipoproteins— may play a crucial role in promoting cell mobility. On the contrary, high levels of HDL cholesterol —the one carried by high-density lipoproteins— may avoid cell propagation. This is a key study to better understand cancer metastasis, the process in which cancer cells invade healthy tissues, and foster the discussion on the relationship between cholesterol levels and cancer incidence.

Daniel Grinberg and Lluïsa Vilageliu, from the Department of Genetics of the Faculty of Biology, and Joan Blasi, from the Department of Pathology and Experimental Therapy of the Faculty of Medicine, participated in the paper, published on the journal Cell Reports. Researchers from the Garvan Institute of Medical Research, the University of Sidney (Australia), Queensland University of Technology (Brisbane, Australia) and the University of Hamburg (Germany) also collaborated in the study.

The study was developed by means of experiments carried out with cell cultures of patients with Niemann-Pick disease. These people present a genetic anomaly that causes cholesterol accumulation in the cell; that produces different motor and neurological disorders. “It is generally thought that cholesterol, one of the most important lipids in our body, is in the blood; but few people ask themselves what cholesterol does in the cell”, points out Carles Enrich. “Cholesterol —adds the researcher— plays different functions in the cell. Besides being crucial to produce membranes, it also regulates vesicular trafficking. Now, it has been proved that cholesterol plays a key role in the regulation of other mechanisms, for instance cell mobility and propagation and, therefore, it is a crucial factor in metastasis”.

Most cells in our body bind other cells by means of integrins, molecules that act as bridges located at the cell surface. UB researchers explored how integrins move in the cells and discovered cholesterolʼs key role. Enrich points out that “in the cell, cholesterol controls the trafficking of vesicles, which are responsible for transporting integrins to cell surface. Cholesterol depletion in the trans-Golgi network interferes integrin trafficking which has direct repercussions on cell migration”.

 

New knowledge about the mechanisms of cancer metastasis

The study provides new therapeutic options to control metastasis and points out a strategy to be applied to cancer patients who also have cholesterol disorders. “It must be considered that the drugs prescribed to regulate cholesterol may modify cell migration ability. Therefore, progress in personalized therapy is absolutely important”, highlights Enrich.

Now, researchersʼ challenge is to understand why cholesterol stays in the cell. “We want to study what endosome membrane mechanisms block intracellular traffic and hold cholesterol and their negative consequences for our health”, concludes Carles Enrich.